Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (281-290 of 326) with videos related to

Pageof 33
Sort By:
International Journal of Cancer|October 9, 1996
Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell linesW J Wasilenko, A J Palad, K D Somers, et al.
European Journal of Medical Research|November 21, 2007
Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgeryH Matthaei, E Boelke, C F Eisenberger, et al.
Clinical Chemistry|September 27, 2002
Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patientsYinsheng Qu, Bao-Ling Adam, Yutaka Yasui, et al.
Urology|January 11, 1991
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study GroupM S Soloway, G Chodak, N J Vogelzang, et al.
Urology|July 31, 2013
Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancerTomasz M Beer, Paul F Schellhammer, John M Corman, et al.
The Journal of Urology|August 19, 2007
Computer modeling technology to assess extracapsular tissue coverage of whole mount sections after retropubic and laparoscopic radical prostatectomyPaul F Schellhammer, Jose I Diaz, Michael D Fabrizio, et al.
BJU International|June 15, 1999
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancerM F Sarosdy, P F Schellhammer, M S Soloway, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesG L Wright, L H Cazares, S-M Leung, et al.
Clinical Chemistry|July 28, 2004
Protein profiling in urine for the diagnosis of bladder cancerAntonia Vlahou, Aris Giannopoulos, Betsy W Gregory, et al.
The Prostate|January 19, 2000
Identification of a superimmunoglobulin gene family member overexpressed in benign prostatic hyperplasia G L Wright, M L Beckett, K R Newhall, et al.
Pageof 33

Showing results (281-290 of 326) with videos related to

Sort By:
Pageof 33
International Journal of Cancer|October 9, 1996
Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell linesW J Wasilenko, A J Palad, K D Somers, et al.
European Journal of Medical Research|November 21, 2007
Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgeryH Matthaei, E Boelke, C F Eisenberger, et al.
Clinical Chemistry|September 27, 2002
Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patientsYinsheng Qu, Bao-Ling Adam, Yutaka Yasui, et al.
Urology|January 11, 1991
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study GroupM S Soloway, G Chodak, N J Vogelzang, et al.
Urology|July 31, 2013
Quality of life after sipuleucel-T therapy: results from a randomized, double-blind study in patients with androgen-dependent prostate cancerTomasz M Beer, Paul F Schellhammer, John M Corman, et al.
The Journal of Urology|August 19, 2007
Computer modeling technology to assess extracapsular tissue coverage of whole mount sections after retropubic and laparoscopic radical prostatectomyPaul F Schellhammer, Jose I Diaz, Michael D Fabrizio, et al.
BJU International|June 15, 1999
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancerM F Sarosdy, P F Schellhammer, M S Soloway, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesG L Wright, L H Cazares, S-M Leung, et al.
Clinical Chemistry|July 28, 2004
Protein profiling in urine for the diagnosis of bladder cancerAntonia Vlahou, Aris Giannopoulos, Betsy W Gregory, et al.
The Prostate|January 19, 2000
Identification of a superimmunoglobulin gene family member overexpressed in benign prostatic hyperplasia G L Wright, M L Beckett, K R Newhall, et al.
Pageof 33